Literature DB >> 19209038

The impact of morbid obesity and bariatric surgery on comorbid conditions: a comprehensive examination of comorbidities in an employed population.

Nathan L Kleinman1, Arthur Melkonian, Spencer Borden, Nicholas Rohrbacker, Wendy D Lynch, Harold H Gardner.   

Abstract

OBJECTIVE: Find conditions with significantly different prevalence among employees diagnosed with morbid obesity (DMO). Examine the effect of bariatric surgery on the prevalence of all categories of comorbid conditions after surgery.
METHODS: This large employer retrospective database analysis used matching to create two cohorts: Those with a DMO and those without.
RESULTS: The DMO cohort had higher diagnosis rates in every Agency for Healthcare Research and Quality major diagnostic category except pregnancy, and it had significantly higher prevalence in 147 of 261 Agency for Health care Research and Quality specific categories. Those electing to undergo bariatric surgery experienced significant prevalence decreases in 26 of 261 specific categories.
CONCLUSION: Employees DMO are at higher risk for many serious diseases. Bariatric surgery has been effective in promoting weight loss and decreasing the rates of many serious comorbidities.

Entities:  

Mesh:

Year:  2009        PMID: 19209038     DOI: 10.1097/JOM.0b013e31818def04

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  8 in total

1.  Utilization rate of bariatric surgery in an employee-based healthcare system following surgery coverage.

Authors:  Keith Kim; Vickie White; Cynthia K Buffington
Journal:  Obes Surg       Date:  2010-11       Impact factor: 4.129

2.  Obesity in the Workplace: Impact, Outcomes, and Recommendations.

Authors:  Charles M Yarborough; Stacy Brethauer; Wayne N Burton; Raymond J Fabius; Pamela Hymel; Shanu Kothari; Robert F Kushner; John Magaña Morton; Kathryn Mueller; Nicolaas P Pronk; Mitchell S Roslin; David B Sarwer; Brian Svazas; Jeffrey S Harris; Garrett I Ash; Jamie T Stark; Marianne Dreger; Julie Ording
Journal:  J Occup Environ Med       Date:  2018-01       Impact factor: 2.162

Review 3.  Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass.

Authors:  M P Hage; G El-Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2013-09-06       Impact factor: 4.507

4.  Early-phase study of a telephone-based intervention to reduce weight regain among bariatric surgery patients.

Authors:  Corrine I Voils; Rachel Adler; Elizabeth Strawbridge; Janet Grubber; Kelli D Allen; Maren K Olsen; Megan A McVay; Sridharan Raghavan; Susan D Raffa; Luke M Funk
Journal:  Health Psychol       Date:  2020-01-30       Impact factor: 4.267

5.  Roux-en-Y Gastric Bypass Improves Hepatic Glucose Metabolism Involving Down-Regulation of Protein Tyrosine Phosphatase 1B in Obese Rats.

Authors:  Song Mu; Jiayu Liu; Wei Guo; Shuping Zhang; Xiaoqiu Xiao; Zhihong Wang; Jun Zhang
Journal:  Obes Facts       Date:  2017-06-01       Impact factor: 3.942

6.  SECONDARY HYPERPARATHYROIDISM AFTER BARIATRIC SURGERY: TREATMENT IS WITH CALCIUM CARBONATE OR CALCIUM CITRATE?

Authors:  Giorgio Alfredo Pedroso Baretta; Maria Paula Carlini Cambi; Arieli Luz Rodrigues; Silvana Aparecida Mendes
Journal:  Arq Bras Cir Dig       Date:  2015

7.  Bone metabolism in Chinese patients after laparoscopic Roux-en-Y gastric bypass.

Authors:  Chen Wang; Hongwei Zhang; Ting Xu; Jian Zou; Jin Chen; Pin Zhang; Zhongmin Shi; Jianzhong Di
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

8.  Protocol and short-term results for a feasibility randomized controlled trial of a video intervention for Veterans with obesity: The TOTAL (Teaching Obesity Treatment Options to Adult Learners) pilot study.

Authors:  Luke M Funk; Catherine R Breuer; Manasa Venkatesh; Anna Muraveva; Esra Alagoz; Bret M Hanlon; Susan D Raffa; Corrine I Voils
Journal:  Contemp Clin Trials Commun       Date:  2021-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.